Beam Therapeutics (BEAM) Other Gross PP&E Adjustments (2019 - 2025)
Beam Therapeutics (BEAM) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $93.5 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 24.2% to $93.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $93.5 million, a 24.2% increase, with the full-year FY2025 number at $93.5 million, up 24.2% from a year prior.
- Other Gross PP&E Adjustments was $93.5 million for Q4 2025 at Beam Therapeutics, down from $96.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $111.5 million in Q2 2022 to a low of -$47.8 million in Q1 2021.
- A 5-year average of $43.9 million and a median of $56.0 million in 2023 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 508.2% in 2021, then skyrocketed 635.49% in 2023.
- Beam Therapeutics' Other Gross PP&E Adjustments stood at -$5.7 million in 2021, then soared by 459.54% to $20.5 million in 2022, then soared by 186.6% to $58.8 million in 2023, then rose by 27.95% to $75.3 million in 2024, then grew by 24.2% to $93.5 million in 2025.
- Per Business Quant, the three most recent readings for BEAM's Other Gross PP&E Adjustments are $93.5 million (Q4 2025), $96.2 million (Q3 2025), and $88.9 million (Q2 2025).